Lunai Bioworks Acquires BBB Delivery Platform for CNS Therapies
Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction...
Keymed Biosciences Reports 2025 Annual Results & Updates
Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. Total revenue in 2025 was approximately...
Seaport Therapeutics Publishes GlyphAllo Prodrug Study in Humans
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated...
Invivoscribe Expands IVDR Portfolio with IdentiClone Dx Assay
IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients...
Dr. Walter Koroshetz Joins APDA Scientific Advisory Board
Renowned neuroscience leader to help evaluate and guide Parkinson’s research funding The American Parkinson Disease Association...
HanchorBio Moves Toward TWSE Innovation Board Listing
Listing milestone positions HanchorBio to strengthen institutional visibility, advance its FBDB™ platform, and expand a growing...
